p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin

Xinbing Sui, Jing Zhu, Haimei Tang, Chan Wang, Jichun Zhou, Weidong Han, Xian Wang, Yong Fang, Yinghua Xu, Da Li,

Oncotarget · 2015 · 21 citations · 24 references

DOIFull text

Open access

Concepts

Abstract

// Xinbing Sui 1, 2, * , Jing Zhu 2, 3, * , Haimei Tang 2 , Chan Wang 2 , Jichun Zhou 4 , Weidong Han 1, 2 , Xian Wang 1, 2 , Yong Fang 1 , Yinghua Xu 1 , Da Li 1 , Rui Chen 2 , Junhong Ma 6 , Zhao Jing 2 , Xidong Gu 5 , Hongming Pan 1, 2 , Chao He 2, 3 1 Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, China 2 Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Zhejiang University, Hangzhou, Zhejiang, China 3 Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, China 4 Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, China 5 Department of Breast Surgery, the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China 6 Department of Gastrointestinal Surgery, Nankai Hospital, Nankai District, Tianjin, China * These authors have contributed equally to this work Correspondence to: Hongming Pan, e-mail: drpanhm@aliyun.com Chao He, e-mail: hechao@163.com Xinbing Sui, e-mail: hzzju@zju.edu.cn Keywords: p53, cancer, cell invasion, NF-κB, Fascin Received: June 05, 2015      Accepted: August 20, 2015      Published: September 01, 2015 ABSTRACT p53 mutation is known to contribute to cancer progression. Fascin is an actin-bundling protein and has been recently identified to promote cancer cell migration and invasion through its role in formation of cellular protrusions such as filopodia and invadopodia. However, the relationship between p53 and Fascin is not understood. Here, we have found a new link between them. In colorectal adenocarcinomas, p53 mutation correlated with high NF-κB, Fascin and low E-cadherin expression. Moreover, this expression profile was shown to contribute to poor overall survival in patients with colorectal cancer. Wild-type p53 could inhibit NF-κB activity that repressed the expression of Fascin and cancer cell invasiveness. In contrast, in p53-deficient primary cultured cells, NF-κB activity was enhanced and then activation of NF-κB increased the expression of Fascin. In further analysis, we showed that NF-κB was a key determinant for p53 deletion-stimulated Fascin expression. Inhibition of NF-κB/p65 expression by pharmacological compound or p65 siRNA suppressed Fascin activity in p53-deficient cells. Moreover, restoration of p53 expression decreased the activation of Fascin through suppression of the NF-κB pathway. Taken together, these data suggest that a negative-feedback loop exists, whereby p53 can suppress colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin.

References

24